BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld
BioWorld
July 30, 2008
View Archived Issues
Rebounding Amgen Trumps Q2 Estimates Despite Profit Decline
Amgen Inc.'s second-quarter earnings outstripped Wall Street expectations and sent shares rising for the second day in a row, signaling a much-needed upturn following a year and a half of negative ESA headlines. (BioWorld Today)
Read More
FDA Panel Backs Approval of Roche IL-6 Arthritis Drug
Read More
Intercept Gets $25M for Bile Acid Trials
Read More
Celator Raises $22.5M for CombiPlex Products Pipeline
Read More
Other News To Note
Read More
Clinic Roundup
Read More